Regenxbio (RGNX) Change in Account Payables (2014 - 2025)

Regenxbio's Change in Account Payables history runs 12 years deep, the most recent figure standing at -$1.9 million for Q4 2025.

• In Q4 2025, Change in Account Payables fell 161.26% year-over-year to -$1.9 million; the TTM figure through Dec 2025 stood at -$2.3 million (down 682.19% YoY), while the FY2025 annual figure was -$2.3 million, down 682.19% from the prior year.
• Change in Account Payables was -$1.9 million for Q4 2025 at Regenxbio, down from $694000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $16.8 million in Q1 2022 to a low of -$14.9 million in Q2 2024.
• Historically, Change in Account Payables has averaged $555950.0 across 5 years, with a median of $957000.0 in 2023.
• Biggest YoY gain for Change in Account Payables was 5926.98% in 2022; the steepest drop was 542.49% in 2022.
• A 5-year view of Change in Account Payables shows it stood at -$8.8 million in 2021, then soared by 121.65% to $1.9 million in 2022, then tumbled by 36.03% to $1.2 million in 2023, then jumped by 149.02% to $3.0 million in 2024, then sank by 161.26% to -$1.9 million in 2025.
• The last three Change in Account Payables figures came in at -$1.9 million (Q4 2025), $694000.0 (Q3 2025), and $2.5 million (Q2 2025), per Business Quant data.